<DOC>
	<DOCNO>NCT02574741</DOCNO>
	<brief_summary>The study consist two main element : enrollment 72 child age 6-11 year ASD low language competency receive thrice-weekly one hour language intervention 12 week ; , begin time , subject equally randomize receive either aripiprazole ( Abilify ) ( flexibly dose 2-10 mg per day ) placebo 12 week .</brief_summary>
	<brief_title>Combination Treatment Augmenting Language Children With ASD</brief_title>
	<detailed_description>Following screen eligibility baseline , study visit schedule three time per week , 2 session on-site UCLA one home parent training ( allow flexibility , need ) ; study physician visit occur weekly 6 week , biweekly . Screening procedure may complete one two visit , measure obtain UCLA clinical research setting may use assessment do within one month screening . Major outcome assessment occur baseline ( Week 0 ) , mid-point ( Week 6 ) , final week ( Week 12 ) study personnel blind visit number drug group assignment ; minor assessment occur weekly along study physician assessment occur weekly side effect compliance check . EEG occur prior baseline Visit 36 ( Wk12 ) . Arrangements make transfer participant standard clinical care follow visit 36 . Six month visit 36 , family see final follow-up assessment language usage , social communication , overall functioning , health ongoing treatment .</detailed_description>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Inclusion criterion : boy girl age 511 year ; criterion autistic disorder PDDNOS define DSMIVTR confirm clinical examination ADIR , ADOS ; low language usage define &lt; 30 functional word obtain natural language sample , parent report , standardized test ; present placement comprehensive educational/intervention set . Exclusion criterion : medical condition would interfere intervention outcomes 12 week study period ( eg. , active seizure within 3 month ) ; genetic disorder Fragile X , Down syndrome , tuberous sclerosis ; sensory impairment deafness blindness ; exist anticipate need concomitant psychotropic medication ( specifically stimulant , atomoxetine ) study participation ( allow medication include : antidepressant , anticonvulsant , guanfacine , clonidine , supplement , melatonin , diphenhydramine ) ; severe aggression selfinjurious behavior ; DQ &lt; 18 month assess LeiterRevised Mullen .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>